Ciprofloxacin

Ciprofloxacin and Tinidazole is a broad-spectrum dual antimicrobial combination. Ciprofloxacin, a fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV, targeting aerobic Gram-negative and Gram-positive bacteria, while tinidazole, a second-generation nitroimidazole, generates free nitro-radicals that damage protozoal and anaerobic DNA. Indicated for mixed aerobic-anaerobic bacterial and protozoal infections, including amoebiasis, giardiasis, bacterial dysentery, pelvic inflammatory disease, and dental abscesses.

Ciprofloxacin and Tinidazole is a broad-spectrum dual antimicrobial combination. Ciprofloxacin, a fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV, targeting aerobic Gram-negative and Gram-positive bacteria, while tinidazole, a second-generation nitroimidazole, generates free nitro-radicals that damage protozoal and anaerobic DNA. Indicated for mixed aerobic-anaerobic bacterial and protozoal infections, including amoebiasis, giardiasis, bacterial dysentery, pelvic inflammatory disease, and dental abscesses.

Ciprofloxacin Hydrochloride is a potent second-generation fluoroquinolone bactericidal antibiotic. It acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing bacterial DNA replication, transcription, and repair. Possesses exceptional activity against aerobic Gram-negative bacilli, including Pseudomonas aeruginosa, Salmonella, Shigella, and Escherichia coli. Indicated for complicated urinary tract infections, pyelonephritis, infectious diarrhea/typhoid, chronic bacterial prostatitis, and bone/joint infections.

Ciprofloxacin Hydrochloride is a potent second-generation fluoroquinolone bactericidal antibiotic. It acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing bacterial DNA replication, transcription, and repair. Possesses exceptional activity against aerobic Gram-negative bacilli, including Pseudomonas aeruginosa, Salmonella, Shigella, and Escherichia coli. Indicated for complicated urinary tract infections, pyelonephritis, infectious diarrhea/typhoid, chronic bacterial prostatitis, and bone/joint infections.

Ciprofloxacin Hydrochloride is a potent second-generation fluoroquinolone bactericidal antibiotic. It acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, preventing bacterial DNA replication, transcription, and repair. Possesses exceptional activity against aerobic Gram-negative bacilli, including Pseudomonas aeruginosa, Salmonella, Shigella, and Escherichia coli. Indicated for complicated urinary tract infections, pyelonephritis, infectious diarrhea/typhoid, chronic bacterial prostatitis, and bone/joint infections.

Ciprofloxacin Eye Drops 0.3% w/v is an evidence-based ophthalmic/otic formulation. It acts by delivering targeted active therapeutic substances to external ocular or auditory tissues to control infection, relieve inflammation, or restore tissue homeostasis.

Ciprofloxacin and Dexamethasone is an antibacterial and anti-inflammatory combination for topical ophthalmic and otic administration. Ciprofloxacin eradicates susceptible ocular and otic bacterial pathogens by inhibiting DNA gyrase, while dexamethasone, a potent corticosteroid, suppresses inflammatory edema, pain, redness, and itching. Indicated for acute otitis media with tympanostomy tubes, acute otitis externa, and bacterial conjunctivitis or post-operative ocular inflammation.